Consolidative immunotherapy well-tolerated in Ewing's tumor

September 2008
Hem/Onc Today;9/10/2008, Vol. 9 Issue 16, p15
The article reports on a study which found that patients with Ewing's tumor and alveolar rhabdomyosarcoma who underwent consolidated immunotherapy aimed at remission generated influenza-specific immune responses. Researchers from the National Cancer Institute and other sites in Maryland and Colorado initiated immunotherapy in 30 patients and divided them into three cohorts. They determined that influenza-specific immune responses occurred in all patients who received immunotherapy.


Related Articles

  • Development of adenoviral vector-based mucosal vaccine against influenza. Tutykhina, Irina L.; Logunov, Denis Y.; Shcherbinin, Dmitriy N.; Shmarov, Maxim M.; Tukhvatulin, Amir I.; Naroditsky, Boris S.; Gintsburg, Alexander L. // Journal of Molecular Medicine;Apr2011, Vol. 89 Issue 4, p331 

    The recent pandemic threat of the influenza virus makes the increased safety and efficiency of vaccination against the pathogen a most important issue. It has been well established that for maximum protective effect, the vaccination should mimic natural infection. Therefore, recent efforts to...

  • Survivors of childhood Ewing's sarcoma at increased risk for mortality, secondary cancers.  // Hem/Onc Today;9/10/2010, Vol. 11 Issue 17, p34 

    The article discusses research on the risk of mortality among survivors of childhood Ewing's sarcoma, by J. P. Ginsberg and colleagues, published in the 2010 issue of the "Journal of National Cancer Institute."

  • Extraosseous Ewing's Sarcoma. Hurie, Justin; Sariego, Jack // American Surgeon;Dec2009, Vol. 75 Issue 12, p1255 

    A letter to the editor is presented about a case of a 66-year-old man with extraosseous Ewing's sarcoma (EOE).

  • Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy. Hamaï, Ahmed; Duperrier-Amouriaux, Karine; Pignon, Pascale; Raimbaud, Isabelle; Memeo, Lorenzo; Colarossi, Cristina; Canzonieri, Vincenzo; Perin, Tiziana; Classe, Jean-Marc; Campone, Mario; Jézéquel, Pascal; Campion, Loïc; Ayyoub, Maha; Valmori, Danila // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    The highly immunogenic human tumor antigen NY-ESO-1 (ESO) is a target of choice for anti-cancer immune therapy. In this study, we assessed spontaneous antibody (Ab) responses to ESO in a large cohort of patients with primary breast cancer (BC) and addressed the correlation between the presence...

  • Parenteral Vaccination against Influenza Does Not Induce a Local Antigen-Specific Immune Response in the Nasal Mucosa. Brokstad, Karl Albert; Eriksson, Jens-Christian; Cox, Rebecca Jane; Tynning, Turid; Olofsson, Jan; Jonsson, Roland; Davidsson, Ake // Journal of Infectious Diseases;4/1/2002, Vol. 185 Issue 7, p878 

    The immune response in the nasal mucosa to influenza vaccination in 23 patients scheduled for tonsillectomy was studied. A statistically significant increase in influenza virus-specific serum and oral fluid antibodies was observed 7 days after vaccination. The numbers of influenza virus ...

  • Flu Fights Dirty. Dunning, Hayley // Scientist;Sep2012, Vol. 26 Issue 9, p49 

    The article focuses on the Hong Kong flu virus discussing the mechanism through which it escapes immune response.

  • Cellular Immune Response May Be Key to Universal Flu Vaccine. Hampton, Tracy // JAMA: Journal of the American Medical Association;10/30/2013, Vol. 310 Issue 17, p1785 

    The article focuses on a study that was conducted by researcher S. Sridhar and colleagues and published in the journal "Nature Medicine," which suggests development of a universal flu vaccine based on T-cell responses to protect from viruses that become resistant to antibody-mediated immunity.

  • Researchers find wide gap in immune responses of people exposed to the flu.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p280 

    The article presents a research study regarding various immune responses of individuals who are succumbed to influenza.

  • Avoiding fatal responses to flu infection.  // Biomedical Market Newsletter;9/26/2011, Vol. 21, p616 

    The article reports that researchers have traced the severe immune response into cytokine storm to help avoid fatal responses in flu infections.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics